Back

The DUAL-ACS Trial: Duration of DAPT in ACS

31 August 2025 (09:09 - 09:19)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor David Newby

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

14 More presentations in this session

Presentation thumbnail
SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease
Professor M. Falkenberg (Gothenburg, SE)
Slides Video
Presentation thumbnail
Discussant review - SWEDEPAD 1 and 2
Professor M. Brodmann (Graz, AT)
Slides Video
Presentation thumbnail
Panel discussion - SWEDEPAD 1 and 2
Presentation thumbnail
The PULSE randomized controlled trial
Doctor O. De Filippo (Turin, IT)
Slides Video
Presentation thumbnail
Discussant review - PULSE
Doctor G. Stone (New York City, US)
Slides Video

Access the full session

Session thumbnail
HOT LINE 6
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 09:09 CET
You may be interested in
thumbnail
Congress Session
Ask the Trialists - DUAL-ACS
31 August 2025
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy for percutaneous coronary intervention following acute coronary syndrome: a meta-analysis of randomized clinical trials
30 August 2025
thumbnail
Congress Presentation
Risk score guided dual antiplatelet therapy duration in patients with acute coronary syndrome: insights from the FORCE-ACS registry
30 August 2024
thumbnail
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources